StonvexLoading…
StonvexStonvexStonvexCore line items from ARRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.28B | $915.81M | $1.58B | $1.64B |
Operating Income | $-29.00M | $-227.00M | $214.12M | $-18.13M |
Net Income | $-52.23M | $-240.39M | $137.24M | $4.43M |
EPS (Diluted) | $-0.73 | $-1.95 | $0.56 | $-0.29 |
Total Assets | $1.45B | $1.43B | $1.71B | $1.71B |
Total Liabilities | $1.19B | $1.14B | $1.10B | $1.28B |
Cash & Equivalents | $244.39M | $362.99M | $249.08M | $133.90M |
Free Cash Flow OCF − CapEx | $79.81M | $146.68M | $214.97M | $130.87M |
Shares Outstanding | 152.54M | 151.75M | 152.02M | 149.82M |